Feldan Therapeutics
Company type: Therapeutics
Main focus: Proprietary peptide-based delivery technology called Feldan Shuttle.
Company stage: Pre-clinical
Diseases: Basal cell carcinoma
Genome-editing tool: CRISPR-Cas
Funding stage: Grant II
Location: Quebec, Qc, Canada
Website: https://www.feldan.com/about
Pipeline: https://www.feldan.com/therapeutic-focus
Partners: Elasmogen
Feldan Therapeutics is a biotech company specialising in the development of novel therapies using a proprietary peptide-based delivery technology called Feldan Shuttle. The Feldan Shuttle technology enables efficient intracellular delivery of various molecules, including proteins, antibodies, and nucleic acids.